Launch of APACMed/ KPMG MedTech Footprint Report and Discussion with EDB
Chris HardestyWeng Si Ho

By 2020, Asia Pacific is expected to surpass the European Union as the world's second-largest med-tech market.

For the first time, APACMed has teamed with KPMG to map the significant social and economic contribution of our industry across APAC in terms of improving healthcare outcomes, driving growth and fostering innovation.



Join us to find out more about the research carried out by KPMG, and hear more from EDB about Singapore’s strategic role as a regional MedTech Hub.

  • Chris Hardesty (Director, Life Sciences Practice, KPMG)

    Chris Hardesty

    Director, Life Sciences Practice, KPMG
  • Weng Si Ho (Director, Healthcare, EDB Singapore)

    Weng Si Ho

    Director, Healthcare, EDB Singapore
APACMed Members’ Networking